Victory Capital Management
MIRM icon

Victory Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Victory Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.12M Sell
60,861
-34,694
-36% -$3.48M ﹤0.01% 1256
2026
Q1 		$8.83M Buy
95,555
+23,361
+32% +$2.2M 0.01% 1119
2025
Q4 		$5.7M Buy
72,194
+58,951
+445% +$4.23M ﹤0.01% 1256
2025
Q3 		$971K Sell
13,243
-91
-0.7% -$5.79K ﹤0.01% 1853
2025
Q2 		$679K Buy
13,334
+8,614
+183% +$384K ﹤0.01% 1985
2025
Q1 		$213K Buy
+4,720
New +$222K ﹤0.01% 2207
2024
Q1 		– Sell
-20,120
Closed -$594K – 2534
2023
Q4 		$594K Buy
+20,120
New +$609K ﹤0.01% 1951
2022
Q4 		– Sell
-694,364
Closed -$14.6M – 2667
2022
Q3 		$14.6M Buy
694,364
+641,804
+1,221% +$15.5M 0.02% 934
2022
Q2 		$1.02M Buy
52,560
+3,210
+7% +$75.7K ﹤0.01% 1735
2022
Q1 		$1.09M Buy
+49,350
New +$1.01M ﹤0.01% 1767
2020
Q2 		– Sell
-1,979
Closed -$28K – 2959
2020
Q1 		$28K Buy
+1,979
New +$32.5K ﹤0.01% 2706

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management's MIRM Position: Q2 2026 in Review

Victory Capital Management reduced its Mirum Pharmaceuticals (MIRM) stake by 36% in Q2 2026, selling an estimated $3.48M and leaving 60,861 shares worth $7.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Victory Capital Management first reported a position in MIRM in Q1 2020 and has held it in 11 quarters since. The position peaked at $14.6M in Q3 2022. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Victory Capital Management held 60,861 shares of Mirum Pharmaceuticals worth $7.12M as of Q2 2026.
  • Victory Capital Management sold 34,694 Mirum Pharmaceuticals shares in Q2 2026, an estimated $3.48M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1256 holding.
  • Victory Capital Management first reported a position in Mirum Pharmaceuticals in Q1 2020 and has held it in 11 quarters since.
  • Victory Capital Management's Mirum Pharmaceuticals position peaked at $14.6M in Q3 2022.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.